Does thromboprophylaxis prevent VTE in outpatients with cancer receiving chemotherapy?
Outpatient chemotherapy patients are at increased risk for VTE and bleeding, requiring careful risk-benefit assessment before initiating thromboprophylaxis.
Those undergoing chemotherapy as outpatients are at increased risk for VTE and for major bleeding complications. Thromboprophylaxis may be considered for such patients after carefully assessing the risks and benefits of treatment.
Lyman et al. (2013) studied this question.